Trial Profile
Pharmacokinetics and pharmacodynamics of escalating single and multiple doses of ONO 5334 in Japanese women with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2014
Price :
$35
*
At a glance
- Drugs ONO 5334 (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 29 Mar 2014 New trial record
- 01 Mar 2014 Pooled population pharmacokinetic/pharmacodynamic analysis published in the Journal of Clinical Pharmacology.